Branded Legacy, Inc.

About Branded Legacy, Inc.

Branded Legacy, through its Bio Legacy Evaluative Group, focuses on addressing the global health crisis of addictions by developing innovative technology and assembling world leaders to improve treatment options. Their mission is to enhance intranasal drug delivery systems, making treatments more accessible, cost-effective, and efficient.

Products & Services

Naloxone Intranasal Device:An all-in-one intranasal delivery device for naloxone, designed to reduce costs, improve dosing precision, and simplify usage compared to current market products.

Second Intranasal Device for Vaccines and Medications:A device allowing mixing of solutions with lyophilized powder, enabling intranasal delivery of vaccines and other cold-chain medications, facilitating quicker pandemic response and access in underserved regions.

Specialties

Intranasal Drug Delivery Medical Device Innovation Addiction Treatment Vaccine Delivery Solutions Cold Chain Medication Logistics

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Funding Round T: - FT: N/A	A: 320000 MR: - FA: $320,000 FAN: 320000	D: 2023-05-12 FD: 2023-05-12	-

Funding Round Latest

2023-05-12

$320K

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

A

Amin Jan

President & CEO

P

Prof Sonal Singh, MD

Medical Lead

P

Prof Eran Bendavid, MD

Research Lead

P

Prof Martin Schechter, MD, PhD

Epidemiology Lead

D

Dr Kristian Thorlund, MD

Founder

D

Dr Scott MacDonald, MD

Addiction Medicine Specialist

View 4 more team members with Pro

Unlock Full Team Directory

Recent News